Rutter, K; Ferlitsch, A; Maieron, A; Stattermayer, AF; Graziadei, I; Dulic, M; Gschwantler, M; Stauber, R; Hofer, H; Peck-Radosavljevic, M; Vogel, W; Trauner, M; Ferenci, P.
SAFETY OF TRIPLE THERAPY WITH TELAPREVIR OR BOCEPREVIR IN HEPATITIS C PATIENTS WITH ADVANCED LIVER DISEASE - PREDICTIVE FACTORS FOR SEPSIS
J HEPATOL. . 2013; 58: S30-S30.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(13)60067-7
[Poster]
Web of Science
FullText
FullText_MUG